ClassID:

21032

A61K38/482 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4) Serine endopeptidases (3.4.21)

Recent Application in this class:
#301
20150297685
2015-10-22

FIBRINOLYTIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PHLEBOTHROMBOTIC STATES

#302
20150290254
2015-10-15

Blends of strains and enzymes

#303
20150266935
2015-09-24

Peptide directed protein knockdown

#304
20150258193
2015-09-17

Diagnostic marker for treatment of cerebral ischemia

#305
20150238502
2015-08-27

Compositions and Methods for Treating Stroke

#306
20150231213
2015-08-20

Nutritional compositions containing a prebiotic and lactoferrin and uses thereof

#307
20150223747
2015-08-13

PATIENT REPORTED OUTCOME INSTRUMENT

#308
20150197738
2015-07-16

Acid Stable Prolyl Endopeptidases for Degrading Gluten

#309
20150190482
2015-07-09

Plasminogen activator mutants as anti-fibrinolytic agents

#310
20150190425
2015-07-09

MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE

#311
20150183844
2015-07-02

CHIMERIC NEUREGULINS AND METHOD OF MAKING AND USE THEREOF

#312
20150182659
2015-07-02

METHODS AND KITS FOR REVERSIBLE ADHESION OF IMPLANTS TO AN EYE SCLERA

#313
20150182607
2015-07-02

Use of proteases for gluten intolerance

#314
20150175994
2015-06-25

Heat-inactivated complement factor B compositions and methods

#315
20150157697
2015-06-11

LACTOFERRIN SUPPLEMENTATION AND DIARRHEA

#316
20150150803
2015-06-04

AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS

#317
20150147401
2015-05-28

Controlled release of biological entities

#318
20150147276
2015-05-28

NANOTHERAPEUTICS FOR DRUG TARGETING

#319
20150132276
2015-05-14

CARTILAGE REGENERATION-PROMOTING AGENT

#320
20150118288
2015-04-30

Lipid nanoparticle compositions and methods of making and methods of using the same

#321
20150118219
2015-04-30

Use of seaprose to remove bacterial biofilm

#322
20150093372
2015-04-02

Gelatinase inhibitors and prodrugs

#323
20150079068
2015-03-19

Formulations of recombinant furin

#324
20150071988
2015-03-12

Sterically Stabilized Carrier For Aerosol Therapeutics, Compositions And Methods For Treating The Respiratory Tract Of A Mammal

#325
20150064267
2015-03-05

Nanoparticles for controlled lysis of blood clots

#326
20150031544
2015-01-29

Dry glassy composition comprising a bioactive material

#327
20140369995
2014-12-18

Combination therapy for treatment of patients with neurological disorders and cerebral infarction

#328
20140364489
2014-12-11

Pharmaceutical Composition Producing antioxidant, antimicrobal, antitoxic protein - human lactoferrin, production process and therapeutic method.

#329
20140341881
2014-11-20

USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES

#330
20140335186
2014-11-13

METHODS AND COMPOSITIONS FOR ENHANCING CD4+ REGULATORY T CELLS

#331
20140322196
2014-10-30

LACTOFERRIN DERIVED PEPTIDES FOR USE AS BROAD-SPECTRUM INHIBITORS OF INFLUENZA VIRUS INFECTION

#332
20140314736
2014-10-23

NOVEL PATIENT SUBGROUPS FOR THROMBOLYSIS

#333
20140308342
2014-10-16

REPROGRAMMING UROKINASE INTO AN ANTIBODY-RECRUITING ANTICANCER AGENT

#334
20140286954
2014-09-25

Tau protease compositions and methods of use

#335
20140271902
2014-09-18

Particulate hyaluronic acid and flavonoid formulations for cellular delivery of bioactive agents

#336
20140271724
2014-09-18

Methods and compositions for treating cancer

#337
20140271609
2014-09-18

Methods of treatment of cellulite

#338
20140248258
2014-09-04

METHODS FOR IMPROVING GUT HEALTH

#339
20140243255
2014-08-28

Treatments for

#340
20140242062
2014-08-28

Modified MT-SP1 proteases that inhibit complement activation

#341
20140234290
2014-08-21

Modified factor X polypeptides and uses thereof

#342
20140227247
2014-08-14

Chimeric neuregulins and method of making and use thereof

#343
20140220030
2014-08-07

Use of CGRP antagonist compounds for treatment of psoriasis

#344
20140219990
2014-08-07

WOUND CLEANING CHEMICAL COMPOSITION AND METHOD FOR MANUFACTURING

#345
20140219969
2014-08-07

Cell therapy for the treatment of neurodegeneration

#346
20140212405
2014-07-31

Fibrinolytic/Proteolytic Treatment of Myofacial and Neuropathic Pain and Related Conditions

#347
20140205587
2014-07-24

Proteases for Degrading Gluten

#348
20140194551
2014-07-10

Aerogel compositions

#349
20140154235
2014-06-05

WOUND DEBRIDEMENT COMPOSITIONS CONTAINING SEAPROSE AND METHODS OF WOUND TREATMENT USING SAME

#350
20140140979
2014-05-22

Compositions and methods of use of phorbol esters for the treatment of stroke

#351
20140134641
2014-05-15

MASP-2, a complement fixing enzyme, and uses for it

#352
20140127185
2014-05-08

METHODS AND COMPOSITIONS USING NEUROPROTECTIVE STEROIDS AND THROMBOLYTIC AGENTS

#353
20140088009
2014-03-27

Chimeric neuregulins and method of making and use thereof

#354
20140086897
2014-03-27

Chimeric neuregulins and method of making and use thereof

#355
20140086872
2014-03-27

Methods of treating a subject for a condition

#356
20140037664
2014-02-06

protein in for use as a medicament

#357
20140030247
2014-01-30

Modified factor X polypeptides and uses thereof

#358
20140030194
2014-01-30

Compositions and methods for the treatment of hepatic diseases and disorders

#359
20140004099
2014-01-02

DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY

#360
20130344056
2013-12-26

KERATIN BIOMATERIALS FOR TREATMENT OF ISCHEMIA

#361
20130323227
2013-12-05

PHARMACEUTICAL COMPOSITIONS OF TENECTEPLASE

#362
20130323219
2013-12-05

Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis

#363
20130316455
2013-11-28

Method of isolating cells from a tissue in a mammal

#364
20130315937
2013-11-28

Lipid nanoparticle compositions for antisense oligonucleotides delivery

#365
20130309221
2013-11-21

Method for inducing tissue growth, differentiation and/or regeneration by delivering a GDF-5 related precursor protein

#366
20130302296
2013-11-14

Treatment and prophylaxis for obsessive compulsive disorder

#367
20130295643
2013-11-07

Non-cytotoxic protein conjugates

#368
20130273116
2013-10-17

ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL

#369
20130273081
2013-10-17

VACCINATION AGAINST PCSKK 9 FOR LOWERING CHOLESTEROL

#370
20130273020
2013-10-17

ANTIFUNGAL COMPOSITION

#371
20130259933
2013-10-03

Capsule which disintegrates specifically in the large intestine

#372
20130259853
2013-10-03

Treatment of acute ischemic stroke or intracranial bleeding with tPa and carbamylated erythropoietin

#373
20130224834
2013-08-29

ANTI-ANDROGENIC AGENT, SEBUM SECRETION BLOCKER, HAIR GROWTH STIMULANT, AND FOOD OR BEVERAGE

#374
20130218122
2013-08-22

Integrated infusion container

#375
20130216518
2013-08-22

COMPOSITION COMPRISING A COMBINATION OF AT LEAST ONE PROTEOLYTIC ENZYME AND AT LEAST ONE LIPOLYTIC ENZYME, FOR USE IN PREVENTING TRIGLYCERIDE SYNTHESIS

#376
20130209442
2013-08-15

WOUND CLEANING CHEMICAL COMPOSITION AND METHOD FOR MANUFACTURING

#377
20130171109
2013-07-04

species gluten-degrading enzymes and uses thereof

#378
20130156884
2013-06-20

PROTEASE ENZYMES FOR INCREASED PROTEIN DIGESTION RATE AND ABSORPTION AND METHODS OF USING THE SAME

#379
20130156785
2013-06-20

NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES

#380
20130149295
2013-06-13

FURIN AND BIOLOGICALLY ACTIVE DERIVATIVES THEREOF FOR USE IN THE PREVENTION OR TREATMENT OF AN INFLAMMATORY DISEASE

#381
20130108610
2013-05-02

Inhibition of microbial growth by aconitase inhibition

#382
20130101575
2013-04-25

LACTOFERRIN SEQENCES, COMPOSITIONS AND METHODS FOR CORNEAL WOUND TREATMENT

#383
20130078705
2013-03-28

PROTEASE FOR TREATING NAIL ABNORMALITIES

#384
20130052184
2013-02-28

Gelatinase inhibitors and prodrugs

#385
20130034531
2013-02-07

Use of proteases for gluten intolerance

#386
20130017173
2013-01-17

Compositions and methods for treating inflammatory bowel disease and airway inflammation

#387
20130004565
2013-01-03

Proteolytic enzyme formulations

#388
20120329128
2012-12-27

Formulations of recombinant furin

#389
20120328601
2012-12-27

Modulation of synaptic maintenance

#390
20120328600
2012-12-27

Injection of fibrin sealant using reconstituted components in spinal applications

#391
20120322663
2012-12-20

Dry glassy composition comprising a bioactive material

#392
20120310034
2012-12-06

Devices for controlling magnetic nanoparticles to treat fluid obstructions

#393
20120296149
2012-11-22

Methods of controlling magnetic nanoparticles to improve vascular flow

#394
20120276075
2012-11-01

SYNERGIC ACTION OF A PROLYL PROTEASE AND TRIPEPTIDYL PROTEASES

#395
20120245080
2012-09-27

MINERAL SALT-SULFONIC ACID COMPOSITIONS AND METHODS OF USE

#396
20120244139
2012-09-27

Modified proteases that inhibit complement activation

#397
20120232329
2012-09-13

Magnetic-based methods for treating vessel obstructions

#398
20120230975
2012-09-13

Fusion proteins

#399
20120226093
2012-09-06

Magnetic-based systems for treating occluded vessels

#400
20120225050
2012-09-06

Methods for improving gut health

#401
20120220517
2012-08-30

Glycopegylation methods and proteins/peptides produced by the methods

#402
20120219965
2012-08-30

MASP 2, a complement-fixing enzyme, and uses for it

#403
20120207741
2012-08-16

Enzymes For Pharmaceutical Use

#404
20120189610
2012-07-26

Treatment of pain

#405
20120156253
2012-06-21

Enzyme treatment of foodstuffs for celiac sprue

#406
20120148567
2012-06-14

Particulate hyaluronic acid/flavonoid suspensions for cellular delivery of bioactive agents

#407
20120087905
2012-04-12

Treatment of diseases related to hyperactivity of the complement system

#408
20120083828
2012-04-05

Apparatus and method for delivery of biological sealant

#409
20120083004
2012-04-05

Diagnostic method for celiac sprue

#410
20120058537
2012-03-08

CHIMERIC TRUNCATED AND MUTANT VARIANT OF TISSUE PLASMINOGEN ACTIVATOR (T-PA) RESISTANT TO PLASMINOGEN ACTIVATOR INHIBITOR-1

#411
20120058098
2012-03-08

Non-cytotoxic protein conjugates

#412
20120045426
2012-02-23

COMPOSITIONS FOR REDUCING THE DELETERIOUS EFFECTS OF STRESS AND AGING

#413
20110311509
2011-12-22

Treatment of ocular diseases

#414
20110300161
2011-12-08

Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma

#415
20110293724
2011-12-01

Enzyme treatment of foodstuffs for celiac sprue

#416
20110250183
2011-10-13

Combination therapy for treatment of patients with neurological disorders and cerebral infarction

#417
20110217285
2011-09-08

Keratin biomaterials for treatment of ischemia

#418
20110212075
2011-09-01

SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS

#419
20110200981
2011-08-18

Polymerized Hemoglobin Media And Its Use In Isolation And Transplantation of Islet Cells

#420
20110200574
2011-08-18

USE OF PROTEASES FOR GLUTEN INTOLERANCE

#421
20110182874
2011-07-28

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#422
20110182873
2011-07-28

Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#423
20110177050
2011-07-21

Methods comprising serratia peptidase for inhibition of osteomyelitis

#424
20110177049
2011-07-21

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#425
20110177048
2011-07-21

Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis

#426
20110171189
2011-07-14

COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS

#427
20110160128
2011-06-30

Corin for Treating Obesity and Diabetes

#428
20110158976
2011-06-30

Enzymes for pharmaceutical use

#429
20110150890
2011-06-23

USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS

#430
20110142987
2011-06-16

Use of proline specific endoproteases to hydrolyse peptides and proteins

#431
20110142808
2011-06-16

Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells

#432
20110130338
2011-06-02

USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES

#433
20110129454
2011-06-02

Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#434
20110117011
2011-05-19

Neutralizing proprotein convertase subtilisin kexin type 9 (PCSK9) variants and uses thereof

#435
20110091437
2011-04-21

FUSION PROTEINS

#436
20110086101
2011-04-14

DispersinB™, 5-fluorouracil, deoxyribonuclease I and proteinase K-based antibiofilm compositions and uses thereof

#437
20110086018
2011-04-14

Proteinases destroy cancer tumor's solid structure and kill cancer cells locally

#438
20110081320
2011-04-07

Treatment/Cure of Autoimmune Disease

#439
20110056408
2011-03-10

AEROGEL COMPOSITIONS

#440
20110053851
2011-03-03

HAEMOSTASIS-MODULATING COMPOSITIONS AND USES THEREFOR

#441
20110052603
2011-03-03

METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME

#442
20100330002
2010-12-30

COMPOSITIONS AND METHODS COMPRISING BASIC AMINO ACID PEPTIDES AND PROTEASES

#443
20100322918
2010-12-23

Diffusion enhancing compounds and their use alone or with thrombolytics

#444
20100322912
2010-12-23

Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Celiac Sprue Patients

#445
20100317025
2010-12-16

Diagnostic method for celiac sprue

#446
20100310451
2010-12-09

ALTERED N-CADHERIN PROCESSING IN TUMOR CELLS BY FURIN AND PROPROTEIN CONVERTASE 5A (PC5A)

#447
20100303887
2010-12-02

DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells

#448
20100273720
2010-10-28

Protective Complement Proteins and Age-Related Macular Degeneration

#449
20100272704
2010-10-28

NOVEL PATIENT SUBGROUPS FOR THROMBOLYSIS

#450
20100269731
2010-10-28

ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL

#451
20100255000
2010-10-07

Antidotes for factor Xa inhibitors and methods of using the same

#452
20100221237
2010-09-02

ENZYME DISRUPTION OF BACTERIAL BIOFILMS

#453
20100196435
2010-08-05

MATERIALS AND METHODS FOR DELIVERING COMPOSITIONS TO SELECTED TISSUES

#454
20100173972
2010-07-08

METHODS AND USES RELATED TO RHBDL4

#455
20100137194
2010-06-03

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

#456
20100135919
2010-06-03

Proteolytic enzyme formulations

#457
20100129342
2010-05-27

Human growth and differentiation factor GDF-5

#458
20100125052
2010-05-20

Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents

#459
20100098682
2010-04-22

Effect of Bri Proteins on Ass Production

#460
20100092451
2010-04-15

Combination enzyme therapy for digestion of dietary gluten

#461
20100080787
2010-04-01

COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN ENZYME WHICH IS INSOLUBLE IN AN AQUEOUS MEDIUM AS WELL AS ITS USES

#462
20100048456
2010-02-25

Glycopegylation methods and proteins/peptides produced by the methods

#463
20100034802
2010-02-11

TREATMENT OF PAIN

#464
20100003237
2010-01-07

Methods of treatment of collagen-mediated diseases and conditions

#465
20090311236
2009-12-17

Therapeutic Peptide Compositions And Methods Of Making And Using Same

#466
20090280555
2009-11-12

ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE

#467
20090259019
2009-10-15

MASP-2, A COMPLEMENT FIXING ENZYME, AND USES FOR IT

#468
20090252808
2009-10-08

Controlled release of biological entities

#469
20090208474
2009-08-20

BIOLOGICAL ENTITIES AND THE USE THEREOF

#470
20090208440
2009-08-20

BIOLOGICAL ENTITIES AND THE USE THEREOF

#471
20090175831
2009-07-09

ADAPTABLE MESSENGER RIBONUCLEIC ACID MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS

#472
20090170182
2009-07-02

Methods for growing tissue with Lopap-based pharmaceutical compositions

#473
20090156490
2009-06-18

PEPTIDES FOR DIAGNOSTIC AND THERAPEUTIC METHODS FOR CELIAC SPRUE

#474
20090130083
2009-05-21

Therapeutic methods that target the NCchannel

#475
20090117092
2009-05-07

Collagenolytic active enzyme containing compositions, and their use in the dental field

#476
20090081184
2009-03-26

NON-PANCREATIC PROTEASES FOR CONTROLLING PLASMA CHOLECYSTOKININ (CCK) CONCENTRATION AND FOR TREATING PAIN

#477
20090010869
2009-01-08

Compositions for Topical Enzymatic Debridement

#478
20080311161
2008-12-18

Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides

#479
20080299108
2008-12-04

Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue

#480
20080286255
2008-11-20

Treatment for eye disorder

#481
20080280825
2008-11-13

Protective complement proteins and age-related macular degenration

#482
20080279872
2008-11-13

Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme

#483
20080269712
2008-10-30

Integrated infusion container

#484
20080254079
2008-10-16

Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology

#485
20080213822
2008-09-04

Methods for diagnosing celiac sprue and reagents useful therein

#486
20080213427
2008-09-04

Enzyme treatment of foodstuffs for celiac sprue

#487
20080213245
2008-09-04

Enzyme treatment of foodstuffs for Celiac Sprue

#488
20080213196
2008-09-04

Enzyme containing composition, process of producing said composition and its use

#489
20080193436
2008-08-14

Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis

#490
20080193389
2008-08-14

Use of glycodendrimer reagents for inhibiting adhesion by microorganisms

#491
20080146501
2008-06-19

Protective complement proteins and age-related macular degeneration

#492
20080145356
2008-06-19

Enzyme treatment of foodstuffs for celiac sprue

#493
20080107640
2008-05-08

BIOLOGICAL PESTICIDE

#494
20080095710
2008-04-24

Enzyme treatment of foodstuffs for celiac sprue

#495
20080060970
2008-03-13

Apparatus and method for delivery of biologic sealant

#496
20080044459
2008-02-21

Enzymatic debridement therapy for abnormal cell proliferation

#497
20080025978
2008-01-31

Method for inhibiting apoptosis through the p75 neurotrophin receptor

#498
20080014190
2008-01-17

Proteinases destroy cancer tumor's solid structure and kill cancer cells locally

#499
20080014169
2008-01-17

Compositions for Topical Enzymatic Debridement

#500
20070280926
2007-12-06

Sting kit apparatus and method of use

#501
20070275085
2007-11-29

Compositions and methods for the cure of HIV / AIDS

#502
20070259053
2007-11-08

Inhibition of nephrotoxicity induced by Trasylol® and like agents

#503
20070258971
2007-11-08

Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis

#504
20070225264
2007-09-27

Drug delivery means

#505
20070218115
2007-09-20

Preparation for Topical Application and Methods of Delivering an Active Agent to a Substrate

#506
20070212342
2007-09-13

Protease compositions for the treatment of damaged tissue

#507
20070196810
2007-08-23

Polymerized Hemoglobin Media and its Use in Isolation and Transplantation of Islet Cells

#508
20070190152
2007-08-16

Method for providing an active agent topically to the skin

#509
20070161572
2007-07-12

Drug therapy for Celiac Sprue

#510
20070148199
2007-06-28

PREPARATIONS FOR TOPICAL SKIN USE AND TREATMENT

#511
20070104706
2007-05-10

Preparation comprising batroxobin for inhibiting local invasion of malignant tumors

#512
20070093443
2007-04-26

Modified proteases that inhibit complement activation

#513
20070081988
2007-04-12

Enzyme inhibitors of PAI-1

#514
20070060517
2007-03-15

Methods for preventing and treating local tracheal, bronchial or alveolar bleeding or hemoptysis

#515
20070031420
2007-02-08

MASP-2, a complement-fixing enzyme, and uses for it

#516
20070031399
2007-02-08

Use of proline specific endoproteases to hydrolyse peptides and proteins

#517
20070026485
2007-02-01

Glycopegylation methods and proteins/peptides produced by the methods

#518
20070003486
2007-01-04

Ointment wound spray

#519
20060240475
2006-10-26

Diagnostic method for Celiac Sprue

#520
20060222641
2006-10-05

Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism

#521
20060210548
2006-09-21

Method for reducing obstructive hydrocephalus

#522
20060189540
2006-08-24

Peptides for diagnostic and therapeutic methods for celiac sprue

#523
20060182732
2006-08-17

Composition for mitigating a pernicious thrombotic event

#524
20060172949
2006-08-03

Compositions for preventing and treating digestive organs diseases

#525
20060134091
2006-06-22

Additive for an animal feed

#526
20060127390
2006-06-15

Enzymatic inactivation of transmissible spongiform encephalopathy agents and dectection there of

#527
20060115436
2006-06-01

Enzyme containing composition, process of producing said composition and its use

#528
20060111285
2006-05-25

Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells

#529
20060110380
2006-05-25

Compositions for inhibiting thrombin-induced coagulation and methods of use

#530
20060104944
2006-05-18

Activators and inhibitors of protease activated receptor2 (PAR2) and methods of use

#531
20060095075
2006-05-04

Injection of fibrin sealant using reconstituted components in spinal applications

#532
20060034847
2006-02-16

Methods of treating a subject for a condition

#533
20060019904
2006-01-26

Composition for promoting lacrimal secretion

#534
20060018896
2006-01-26

Methods for treating conditions associated with lectin-dependent complement activation

#535
20060002917
2006-01-05

Glutenase enzyme assays

#536
20050281806
2005-12-22

Compositions for topical enzymatic debridement

#537
20050272664
2005-12-08

Methods for inhibiting angiogenesis and or lymphangiogenesis

#538
20050265932
2005-12-01

Collagenolytic active enzyme containing compositions, and their use in the dental field

#539
20050256054
2005-11-17

Drug therapy for celiac sprue

#540
20050249719
2005-11-10

Enzyme treatment of foodstuffs for Celiac Sprue

#541
20050220782
2005-10-06

Method of treatment for stroke employing administration of defibrinogenating agents to achieve a specific defibrinogenation pattern

#542
20050220780
2005-10-06

Therapeutic composition containing a plurality of immobilized proteases

#543
20050175581
2005-08-11

Biological entities and the pharmaceutical and diagnostic use thereof

#544
20050158299
2005-07-21

Treating abdominal pain due to pancreatitis with seaprose

#545
20050158297
2005-07-21

MASP-2, a complement-fixing enzyme, and uses for it

#546
20050065089
2005-03-24

TGF-beta activation and use

#547
20050059126
2005-03-17

Engineered enzymes and uses thereof

#548
20050053597
2005-03-10

Composition and method for treatment of wounds

#549
20050048044
2005-03-03

Treatment for dry macular degeneration

#550
20050036950
2005-02-17

Ointment wound spray

#551
20050019319
2005-01-27

Composition for mitigating a pernicious thrombotic event

#552
20050002897
2005-01-06

Biological entities and the pharmaceutical or diagnostic use thereof

#553
17573503
2024-03-26

Compositions and methods for prevention and treatment of coronavirus and related disorders

#554
15147958
2019-06-25

Compositions and methods for treating stroke